Patient Guide: AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 52 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06219941
Status: 🟢 Enrolling Now
Condition: Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
Phase: Phase II

Find a Study Location Near You

This study is available at 52 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Orange, California
  • • Palo Alto, California
  • • Santa Rosa, California
  • • And 49 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 - Join Clinical Trial NCTNCT06219941

How to Join This Clinical Trial - NCTNCT06219941

Learn how to participate in this Phase II trial studying an investigational therapy for Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
Treatment Being Tested
Investigational treatment
Study Phase
Phase II - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06219941 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 52 locations. Find a study site near you:

Clinical Research Site

Orange, California 92868 - United States

Status: RECRUITING

Clinical Research Site

Palo Alto, California 94304 - United States

Status: RECRUITING

Clinical Research Site

Santa Rosa, California 95403 - United States

Status: RECRUITING

Clinical Research Site

Louisville, Kentucky 40202 - United States

Status: RECRUITING

Clinical Research Site

Commack, New York 11725 - United States

Status: RECRUITING

Clinical Research Site

Providence, Rhode Island 02903 - United States

Status: RECRUITING

Clinical Research Site

Houston, Texas 77030 - United States

Status: RECRUITING

Clinical Research Site

Melbourne, 3000 - Australia

Status: RECRUITING

Clinical Research Site

Murdoch, WA6150 - Australia

Status: RECRUITING

Clinical Research Site

Randwick, 2031 - Australia

Status: RECRUITING

And 42 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Phase II clinical trial for Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation